Survey of HIV and hepatitis B or C co-infection management in the UK 2004

International Journal of STD and AIDS

Volumn 17, Issue 12, 2006, Pages 799-801

  De Silva, S ^a   Brook, M G ^b   Curtis, H ^c   Johnson, M ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^c British HIV Association   (United Kingdom)

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Co infection; Hepatitis B; Hepatitis C; HIV

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; INTERFERON; LAMIVUDINE; TENOFOVIR;

DIAGNOSTIC TEST; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LIVER BIOPSY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING; UNITED KINGDOM;

ANTIVIRAL AGENTS; CLINICAL PROTOCOLS; GREAT BRITAIN; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; PREVALENCE; QUESTIONNAIRES;

EID: 33846107490     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646206779307603     Document Type: Review

References (3)

1. Nelson MR, Matthews G, Brook MG, Main J. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and chronic hepatitis C virus infection (2005). HIV Med 2005;6(Suppl 2):96-106
2. Brook MG, Gilson R, Wilkins EL. BHIVA guidelines on HIV and chronic hepatiits: coinfection with HIV and chronic hepatitis B virus infection (2005). HIV Med 2005;6(Suppl 6):84-95
3. BHIVA guidelines for the management of hepatitis B and C coinfection [www.bhiva.org]